You are here

Zelig Eshhar

(l-r) Dr. Ruth Scherz-Shouval, Prof. Drew Pardoll and Dr. Rony Dahan

Prof. Pardoll was the keynote speaker at the recent Cancer Immunotherapy symposium sponsored by the...

Prof. Zelig Eshhar

Prof. Zelig Eshhar

Prof. Zelig Eshhar

Prof. Zelig Eshhar is the recipient of the Teva Award for Excellence in Memory of Eli Hurvitz

Prof. Zelig Eshhar

Prof. Zelig Eshhar was awarded the Massry Prize by the Meira and Shul G. Massry Foundation

Prof. Zelig Eshhar

Prof. Zelig Eshhar is the recipient of the European Society of Gene and Cell Theraphy (ESGCT) and Human Gene Therapy Outstanding Achievement Award...

 SEM image of the dense microbial ecosystem overlying the 'hilly' gastrointestinal epithelial layer

Our complicated relationship with the microorganisms in our gut has some surprising consequences for our health

Prof. Zelig Eshhar. New approach to fighting cancer

Pools of donor immune cells could reduce the cost and expand the applications of an experimental cancer treatment.

Universal Donor Immune Cells

An approach developed at the Weizmann Institute could make a cancer therapy cheaper and more effective

Prof. Meir Wilchek
In the late 1980s, Prof. Meir Wilchek  developed an immune cancer therapy that employs "T bodies" – white...